Next Article in Journal
Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
Next Article in Special Issue
Structure-Based Virtual Screening Allows the Identification of Efficient Modulators of E-Cadherin-Mediated Cell–Cell Adhesion
Previous Article in Journal
Role of B-Cell Translocation Gene 1 in the Pathogenesis of Endometriosis
Previous Article in Special Issue
E-cadherin Beyond Structure: A Signaling Hub in Colon Homeostasis and Disease
Open AccessReview

Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis

Department of Molecular Biomedicine, Centro de Investigaciones Biológicas (CIB)-Consejo Superior de Investigaciones Científicas (CSIC), Ramiro de Maeztu 9, 28039 Madrid, Spain
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(13), 3373; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20133373
Received: 30 May 2019 / Revised: 1 July 2019 / Accepted: 6 July 2019 / Published: 9 July 2019
(This article belongs to the Special Issue Activations of Cadherin Signaling in Cancer)
Cell-cell adhesion molecules (cadherins) and cell-extracellular matrix adhesion proteins (integrins) play a critical role in the regulation of cancer invasion and metastasis. Although significant progress has been made in the characterization of multiple members of the cadherin superfamily, most of the published work continues to focus in the switch E-/N-cadherin and its role in the epithelial–mesenchymal transition. Here, we will discuss the structural and functional properties of a subset of cadherins (cadherin 17, cadherin 5 and cadherin 6) that have an RGD motif in the extracellular domains. This RGD motif is critical for the interaction with α2β1 integrin and posterior integrin pathway activation in cancer metastatic cells. However, other signaling pathways seem to be affected by RGD cadherin interactions, as will be discussed. The range of solid tumors with overexpression or “de novo” expression of one or more of these three cadherins is very wide (gastrointestinal, gynaecological and melanoma, among others), underscoring the relevance of these cadherins in cancer metastasis. Finally, we will discuss different evidences that support the therapeutic use of these cadherins by blocking their capacity to work as integrin ligands in order to develop new cures for metastatic patients. View Full-Text
Keywords: cadherin 17 (CDH17); VE-cadherin; cadherin 6 (CDH6); N-cadherin; α2β1 integrin; RGD motif; metastasis; therapeutic antibodies cadherin 17 (CDH17); VE-cadherin; cadherin 6 (CDH6); N-cadherin; α2β1 integrin; RGD motif; metastasis; therapeutic antibodies
Show Figures

Graphical abstract

MDPI and ACS Style

Casal, J.I.; Bartolomé, R.A. Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis. Int. J. Mol. Sci. 2019, 20, 3373. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20133373

AMA Style

Casal JI, Bartolomé RA. Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis. International Journal of Molecular Sciences. 2019; 20(13):3373. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20133373

Chicago/Turabian Style

Casal, J. I.; Bartolomé, Rubén A. 2019. "Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis" Int. J. Mol. Sci. 20, no. 13: 3373. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20133373

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop